Xiaobin Ma

1.7k citations
64 papers · 1.3k · h-index 21

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Pharmacology top 10%
    • Inflammatory mediators and NSAID effects
    • Flavonoids in Medical Research

Papers in

    • Cancer-related molecular mechanisms research 5
    • MicroRNA in disease regulation 4
    • Cancer-related Molecular Pathways 4
    • PARP inhibition in cancer therapy 4

Xiaobin Ma

62 papers receiving 1.3k citations

Peers

Xiaobin Ma
Comparison fields: 5 of 134
  • Cancer Research 231
  • Pharmacology 146
  • Pathology and Forensic Medicine 111
  • Molecular Biology 446
  • Oncology 162
Replace Yun‐Ju Chen with:
Yun‐Ju Chen Taiwan
Heran Wang China
Bao-Qin Liu China
Lina Yang China
Shidong Wang China
Siliang Wang China
Linghua Meng China
Xiaolong Liu China
Xiaoyu Tan China
Antonio Rodríguez‐Ariza Spain
Xiaobin Ma relative to Yun‐Ju Chen Taiwan Yun‐Ju Chen's profile →
Citations per field
00.5×1.5×2×2.4×
Yun‐Ju Chen · 1×
Citations per year

Countries citing papers authored by Xiaobin Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaobin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Ma more than expected).

Fields of papers citing papers by Xiaobin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Ma. The network helps show where Xiaobin Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaobin Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaobin Ma Line = papers co-authored together Xiaobin Ma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201595
2 201288
3 201283
4 201664
5 201353
6 202251
7 202251
8 202350
9 201548
10 201645
11 201239
12 201839
13 201638
14 201336
15 201733
16 201629
17 201624
18 201323
19 201323
20 201622

About Xiaobin Ma

Xiaobin Ma is a scholar working on Cancer Research, Oncology, Molecular Biology, Global and Planetary Change and Pharmacology, having authored 64 papers that have together received 1.3k indexed citations. Recurring topics across this work include Land Use and Ecosystem Services (7 papers), Cancer-related molecular mechanisms research (5 papers), Cancer-related Molecular Pathways (4 papers), DNA Repair Mechanisms (4 papers), Circular RNAs in diseases (4 papers), PARP inhibition in cancer therapy (4 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (231 citations), Pharmacology (146 citations), Pathology and Forensic Medicine (111 citations), Molecular Biology (446 citations) and Oncology (162 citations). Xiaobin Ma has collaborated with scholars based in China and United States. Frequent co-authors include Xi-Jing Wang, Huafeng Kang, Shuai Lin, Weili Min, Peijia Wang, Haitao Guan, Yi Sun, Jie Gao, Jinhe Zhang and Wenying Wu. Their work appears in journals such as Oncotarget, Medicine, Cancer Cell International, Biochemical and Biophysical Research Communications and International Immunopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact